Moreover, after degradation to SCFAs by the gut microbiota, the TH-CS regulated the AMPK-SREBP1 signaling pathway and the level of PPARγ in the liver to alleviate lipid accumulation and IR in the NAFLD mice. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.